David Steensma, MD | Authors


Dr. David Steensma on Midostaurin and its Future Uses in Acute Leukemia

December 08, 2015

David Steensma, MD, discusses how midostaurin could affect the treatment paradigm for acute leukemia. He says that while midostaurin is not currently approved by the FDA, studies show its potential usefulness when added to conventional induction platforms.